LABEL-FREE ARRAY SYSTEMS MARKET ANALYSIS

Market Challenges And Opportunities

Global Label-Free Array Systems Market Drivers

Increasing adoption of label-free array systems in the drug discovery process is expected to drive the global label-free array systems market growth over the forecast period. For instance, according to the National center for Biotechnology Information, (NCBI), 2016, label-free array systems are extensively used for secondary screening to find the lead molecule for the drug development process from the small molecule hits and it is also used for lead optimization to find the candidate drug from the leads molecules. Moreover, according to the same source, currently the label-free array systems are extensively used for evaluating kinetics between the drug molecule and its receptor, as it is most important bond that is characterized for drug discovery process.  

Leading manufacturers are focused on manufacturing new products in the global label-free array systems market over the forecast period. For instance, in 2018, Bruker Corporation launched a modified version of SPR, Sierra SPR-32 system, with higher sensitivity, modified instrument control software to enable highest SPR throughput with outstanding sensitivity. These factors are expected to drive the global label-free array systems market growth over the forecast period.

Global Label-Free Array Systems Market Restraints

Lack of skilled persons to perform label-free techniques in developed as well as in the emerging economies is expected to hamper growth of the global label-free array systems market over the forecast period. The protocols used in the techniques are very specific and requires a trained person to carry out the procedure. The procedure should be carried out with higher precision and less errors.

Moreover, SPR products are very expensive and this is expected to hinder the growth the market. For instance, cost of imaging systems offered by Biacore (acquired by GE Healthcare) range between US$ 200,000 and US$ 300,000. Moreover, reagents supporting such systems are very costly, which increases the overall cost per interaction. These factors are expected to restrain the global label-free array systems market growth over the forecast period.